Mitomycin Clinical Trials

6 actively recruiting trials across 5 locations

▼ -1 trial since June 2026

Also known as: Ametycine, Jelmyto, MITO, Mito-C, Mito-Medac +13 more

Pipeline

Phase 1: 1Phase 2: 3Phase 3: 1Phase 1/2: 1

Top Sponsors

City of Hope Medical Center2
University of Chicago1
National Cancer Institute (NCI)1
NRG Oncology1
Mayo Clinic1

Indications

Cancer6
Stage I Bladder Cancer AJCC v82
Peritoneal Carcinomatosis2
Stage IVC Appendix Carcinoma AJCC v81
Stage IVB Appendix Carcinoma AJCC v81

Duarte, California2 trials

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center

Phase 1

Phase II Trial of Lung Chemoemobolization

City of Hope Medical Center

Phase 2

Fayetteville, Arkansas1 trial

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Highlands Oncology Group - Fayetteville

Phase 2

Fort Smith, Arkansas1 trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Mercy Hospital Fort Smith

Phase 3

Jacksonville, Florida1 trial

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic in Florida

Phase 1/2

Chicago, Illinois1 trial

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

University of Chicago

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.